The hormone thyrotropin (TSH) and its receptor (TSHR) are crucial for the growth and function of the thyroid gland. The TSHR is evolutionary linked with the receptors of follitropin (FSHR) and lutropin/choriogonadotropin (LHR) and their sequences and structures are similar. The extracellular region of TSHR contains more than 350 amino acids and binds hormone and antibodies. Several important questions related to functions and mechanisms of TSHR are still not comprehensively understood. One major reason for these open questions is the lack of any structural information about the extracellular segment of TSHR that connects the N-terminal leucine-rich repeat domain (LRRD) with the transmembrane helix (TMH) 1, the hinge region. It has been shown experimentally that this segment is important for fine tuning of signaling and ligand interactions. A new crystal structure containing most of the extracellular hFSHR region in complex with hFSH has recently been published. Now, we have applied these new structural insights to the homologous TSHR and have generated a structural model of the TSHR LRRD/hinge-region/TSH complex. This structural model is combined and evaluated with experimental data including hormone binding (bTSH, hTSH, thyrostimulin), super-agonistic effects, antibody interactions and signaling regulation. These studies and consideration of significant and non-significant amino acids have led to a new description of mechanisms at the TSHR, including ligand-induced displacements of specific hinge region fragments. This event triggers conformational changes at a convergent center of the LRRD and the hinge region, activating an “intramolecular agonistic unit” close to the transmembrane domain.
References
[1]
Vassart G, Pardo L, Costagliola S (2004) A molecular dissection of the glycoprotein hormone receptors. Trends BiochemSci 29: 119–126.
[2]
Kleinau G, Krause G (2009) Thyrotropin and homologous glycoprotein hormone receptors: structural and functional aspects of extracellular signaling mechanisms. Endocr Rev 30: 133–151.
[3]
Braun T, Schofield PR, Sprengel R (1991) Amino-terminal leucine-rich repeats in gonadotropin receptors determine hormone selectivity. EMBO J 10: 1885–1890.
[4]
Nagayama Y, Rapoport B (1992) Role of the carboxyl-terminal half of the extracellular domain of the human thyrotropin receptor in signal transduction. Endocrinology 131: 548–552.
[5]
Nagayama Y, Wadsworth HL, Chazenbalk GD, Russo D, Seto P, et al. (1991) Thyrotropin-luteinizing hormone/chorionic gonadotropin receptor extracellular domain chimeras as probes for thyrotropin receptor function. Proc Natl Acad Sci U S A 88: 902–905.
[6]
Angelova K, de Jonge H, Granneman JC, Puett D, Bogerd J (2010) Functional differences of invariant and highly conserved residues in the extracellular domain of the glycoprotein hormone receptors. J Biol Chem 285: 34813–34827.
[7]
Caltabiano G, Campillo M, De Leener A, Smits G, Vassart G, et al. (2008) The specificity of binding of glycoprotein hormones to their receptors. Cell Mol Life Sci 65: 2484–2492.
[8]
Smits G, Campillo M, Govaerts C, Janssens V, Richter C, et al. (2003) Glycoprotein hormone receptors: determinants in leucine-rich repeats responsible for ligand specificity. EMBO J 22: 2692–2703.
[9]
Enkhbayar P, Kamiya M, Osaki M, Matsumoto T, Matsushima N (2004) Structural principles of leucine-rich repeat (LRR) proteins. Proteins 54: 394–403.
[10]
He XL, Bazan JF, McDermott G, Park JB, Wang K, et al. (2003) Structure of the Nogo receptor ectodomain: a recognition module implicated in myelin inhibition. Neuron 38: 177–185.
[11]
Kleinau G, Jaschke H, Neumann S, Lattig J, Paschke R, et al. (2004) Identification of a novel epitope in the thyroid-stimulating hormone receptor ectodomain acting as intramolecular signaling interface. J Biol Chem 279: 51590–51600.
[12]
Nunez Miguel R, Sanders J, Jeffreys J, Depraetere H, Evans M, et al. (2004) Analysis of the thyrotropin receptor-thyrotropin interaction by comparative modeling. Thyroid 14: 991–1011.
[13]
Kobe B, Deisenhofer J (1995) A structural basis of the interactions between leucine-rich repeats and protein ligands. Nature 374: 183–186.
Kajava AV (1998) Structural diversity of leucine-rich repeat proteins. J Mol Biol 277: 519–527.
[16]
Bhowmick N, Huang J, Puett D, Isaacs NW, Lapthorn AJ (1996) Determination of residues important in hormone binding to the extracellular domain of the luteinizing hormone/chorionic gonadotropin receptor by site-directed mutagenesis and modeling. Mol Endocrinol 10: 1147–1159.
[17]
Kleinau G, Mueller S, Jaeschke H, Grzesik P, Neumann S, et al. (2011) Defining structural and functional dimensions of the extracellular thyrotropin receptor region. J Biol Chem 286: 22622–22631.
[18]
Jaeschke H, Neumann S, Kleinau G, Mueller S, Claus M, et al. (2006) An aromatic environment in the vicinity of serine 281 is a structural requirement for thyrotropin receptor function. Endocrinology 147: 1753–1760.
[19]
Vlaeminck-Guillem V, Ho SC, Rodien P, Vassart G, Costagliola S (2002) Activation of the cAMP pathway by the TSH receptor involves switching of the ectodomain from a tethered inverse agonist to an agonist. Mol Endocrinol 16: 736–746.
[20]
Zhang M, Tong KP, Fremont V, Chen J, Narayan P, et al. (2000) The extracellular domain suppresses constitutive activity of the transmembrane domain of the human TSH receptor: implications for hormone-receptor interaction and antagonist design. Endocrinology 141: 3514–3517.
[21]
Fan QR, Hendrickson WA (2005) Structure of human follicle-stimulating hormone in complex with its receptor. Nature 433: 269–277.
[22]
Sanders P, Young S, Sanders J, Kabelis K, Baker S, et al. (2011) Crystal structure of the TSH receptor (TSHR) bound to a blocking-type TSHR autoantibody. J Mol Endocrinol 46: 81–99.
[23]
Sanders J, Chirgadze DY, Sanders P, Baker S, Sullivan A, et al. (2007) Crystal structure of the TSH receptor in complex with a thyroid-stimulating autoantibody. Thyroid 17: 395–410.
[24]
Fan QR, Hendrickson WA (2007) Assembly and structural characterization of an authentic complex between human follicle stimulating hormone and a hormone-binding ectodomain of its receptor. MolCell Endocrinol 260–262: 73–82.
[25]
Fan QR, Hendrickson WA (2008) Comparative structural analysis of the binding domain of follicle stimulating hormone receptor. Proteins 72: 393–401.
[26]
Agrawal G, Dighe RR (2009) Critical involvement of the hinge region of the follicle-stimulating hormone receptor in the activation of the receptor. JBiolChem 284: 2636–2647.
[27]
Ho SC, Goh SS, Su Q, Khoo DH (2005) Cysteine 390 mutation of the TSH receptor modulates its ectodomain as an inverse agonist on the serpentine domain with decrease in basal constitutive activity. Mol Cell Endocrinol 245: 158–168.
[28]
Ho SC, Van Sande J, Lefort A, Vassart G, Costagliola S (2001) Effects of mutations involving the highly conserved S281HCC motif in the extracellular domain of the thyrotropin (TSH) receptor on TSH binding and constitutive activity. Endocrinology 142: 2760–2767.
[29]
Jaquette J, Segaloff DL (2002) Constitutive activation of the LH receptor is associated with an alteration in the conformation of the ectodomain. Mol Cell Endocrinol 194: 211–215.
[30]
Mizutori Y, Chen CR, McLachlan SM, Rapoport B (2008) The thyrotropin receptor hinge region is not simply a scaffold for the leucine-rich domain but contributes to ligand binding and signal transduction. Mol Endocrinol 22: 1171–1182.
[31]
Nakabayashi K, Kudo M, Hsueh AJ, Maruo T (2003) Activation of the luteinizing hormone receptor in the extracellular domain. Mol Cell Endocrinol 202: 139–144.
[32]
Nurwakagari P, Breit A, Hess C, Salman-Livny H, Ben-Menahem D, et al. (2007) A conformational contribution of the luteinizing hormone-receptor ectodomain to receptor activation. J Mol Endocrinol 38: 259–275.
[33]
Sangkuhl K, Schulz A, Schultz G, Schoneberg T (2002) Structural requirements for mutational lutropin/choriogonadotropin receptor activation. J Biol Chem 277: 47748–47755.
[34]
Zhang ML, Sugawa H, Kosugi S, Mori T (1995) Constitutive activation of the thyrotropin receptor by deletion of a portion of the extracellular domain. Biochem Biophys Res Commun 211: 205–210.
[35]
Kleinau G, Brehm M, Wiedemann U, Labudde D, Leser U, et al. (2007) Implications for molecular mechanisms of glycoprotein hormone receptors using a new sequence-structure-function analysis resource. Mol Endocrinol 21: 574–580.
[36]
Kleinau G, Kreuchwig A, Worth CL, Krause G (2010) An interactive web-tool for molecular analyses links naturally occurring mutation data with three-dimensional structures of the rhodopsin-like glycoprotein hormone receptors. Hum Mutat 31: E1519–1525.
[37]
Kreuchwig A, Kleinau G, Kreuchwig F, Worth CL, Krause G (2011) Research resource: Update and extension of a glycoprotein hormone receptors web application. Mol Endocrinol 25: 707–712.
[38]
Hamidi S, Chen CR, Mizutori-Sasai Y, McLachlan SM, Rapoport B (2011) Relationship between Thyrotropin Receptor Hinge Region Proteolytic Posttranslational Modification and Receptor Physiological Function. Mol Endocrinol 25: 184–194.
[39]
Bruysters M, Verhoef-Post M, Themmen AP (2008) Asp330 and Tyr331 in the C-terminal cysteine-rich region of the luteinizing hormone receptor are key residues in hormone-induced receptor activation. J Biol Chem 283: 25821–25828.
[40]
Chen CR, Chazenbalk GD, McLachlan SM, Rapoport B (2003) Evidence that the C terminus of the A subunit suppresses thyrotropin receptor constitutive activity. Endocrinology 144: 3821–3827.
[41]
Duprez L, Parma J, Costagliola S, Hermans J, Van Sande J, et al. (1997) Constitutive activation of the TSH receptor by spontaneous mutations affecting the N-terminal extracellular domain. FEBS Lett 409: 469–474.
[42]
Gruters A, Schoneberg T, Biebermann H, Krude H, Krohn HP, et al. (1998) Severe congenital hyperthyroidism caused by a germ-line neo mutation in the extracellular portion of the thyrotropin receptor. J Clin Endocrinol Metab 83: 1431–1436.
[43]
Kopp P, Muirhead S, Jourdain N, Gu WX, Jameson JL, et al. (1997) Congenital hyperthyroidism caused by a solitary toxic adenoma harboring a novel somatic mutation (serine281→isoleucine) in the extracellular domain of the thyrotropin receptor. J Clin Invest 100: 1634–1639.
[44]
Mueller S, Kleinau G, Jaeschke H, Neumann S, Krause G, et al. (2006) Significance of ectodomain cysteine boxes 2 and 3 for the activation mechanism of the thyroid-stimulating hormone receptor. J Biol Chem 281: 31638–31646.
[45]
Nishihara E, Chen CR, Mizutori-Sasai Y, Ito M, Kubota S, et al. (2012) Deletion of thyrotropin receptor residue Asp403 in a hyperfunctioning thyroid nodule provides insight into the role of the ectodomain in ligand-induced receptor activation. J Endocrinol Invest 35: 49–53.
[46]
Chen CR, McLachlan SM, Rapoport B (2011) Evidence that the thyroid-stimulating hormone (TSH) receptor transmembrane domain influences kinetics of TSH binding to the receptor ectodomain. J Biol Chem 286: 6219–6224.
[47]
Zoenen M, Urizar E, Swillens S, Vassart G, Costagliola S (2012) Evidence for activity-regulated hormone-binding cooperativity across glycoprotein hormone receptor homomers. Nat Commun 3: 1007.
[48]
Galet C, Ascoli M (2005) The differential binding affinities of the luteinizing hormone (LH)/choriogonadotropin receptor for LH and choriogonadotropin are dictated by different extracellular domain residues. Mol Endocrinol 19: 1263–1276.
[49]
Costagliola S, Panneels V, Bonomi M, Koch J, Many MC, et al. (2002) Tyrosine sulfation is required for agonist recognition by glycoprotein hormone receptors. EMBO J 21: 504–513.
[50]
Kosugi S, Ban T, Akamizu T, Kohn LD (1991) Site-directed mutagenesis of a portion of the extracellular domain of the rat thyrotropin receptor important in autoimmune thyroid disease and nonhomologous with gonadotropin receptors. Relationship of functional and immunogenic domains. J Biol Chem 266: 19413–19418.
[51]
Mueller S, Kleinau G, Jaeschke H, Paschke R, Krause G (2008) Extended hormone binding site of the human thyroid stimulating hormone receptor: distinctive acidic residues in the hinge region are involved in bovine thyroid stimulating hormone binding and receptor activation. J Biol Chem 283: 18048–18055.
[52]
Mueller S, Kleinau G, Szkudlinski MW, Jaeschke H, Krause G, et al. (2009) The superagonistic activity of bovine thyroid-stimulating hormone (TSH) and the human TR1401 TSH analog is determined by specific amino acids in the hinge region of the human TSH receptor. J Biol Chem 284: 16317–16324.
[53]
Mueller S, Szkudlinski MW, Schaarschmidt J, Gunther R, Paschke R, et al. (2011) Identification of novel TSH interaction sites by systematic binding analysis of the TSHR hinge region. Endocrinology 152: 3268–3278.
[54]
Jiang X, Liu H, Chen X, Chen PH, Fischer D, et al. (2012) Structure of follicle-stimulating hormone in complex with the entire ectodomain of its receptor. Proc Natl Acad Sci U S A 109: 12491–12496.
[55]
Jaeschke H, Schaarschmidt J, Gunther R, Mueller S (2011) The hinge region of the TSH receptor stabilizes ligand binding and determines different signaling profiles of human and bovine TSH. Endocrinology 152: 3986–3996.
[56]
Karges B, Gidenne S, Aumas C, Haddad F, Kelly PA, et al. (2005) Zero-length cross-linking reveals that tight interactions between the extracellular and transmembrane domains of the luteinizing hormone receptor persist during receptor activation. Mol Endocrinol 19: 2086–2098.
[57]
Neumann S, Claus M, Paschke R (2005) Interactions between the extracellular domain and the extracellular loops as well as the 6th transmembrane domain are necessary for TSH receptor activation. Eur J Endocrinol 152: 625–634.
[58]
Jiang X, Dreano M, Buckler DR, Cheng S, Ythier A, et al. (1995) Structural predictions for the ligand-binding region of glycoprotein hormone receptors and the nature of hormone-receptor interactions. Structure 3: 1341–1353.
[59]
Urizar E, Montanelli L, Loy T, Bonomi M, Swillens S, et al. (2005) Glycoprotein hormone receptors: link between receptor homodimerization and negative cooperativity. EMBO J 24: 1954–1964.
[60]
Guan R, Wu X, Feng X, Zhang M, Hebert TE, et al. (2010) Structural determinants underlying constitutive dimerization of unoccupied human follitropin receptors. Cell Signal 22: 247–256.
[61]
Zeng H, Phang T, Song YS, Ji I, Ji TH (2001) The role of the hinge region of the luteinizing hormone receptor in hormone interaction and signal generation. J Biol Chem 276: 3451–3458.
[62]
Bonomi M, Busnelli M, Persani L, Vassart G, Costagliola S (2006) Structural differences in the hinge region of the glycoprotein hormone receptors: evidence from the sulfated tyrosine residues. Mol Endocrinol 20: 3351–3363.
[63]
Hsu SY, Nakabayashi K, Bhalla A (2002) Evolution of glycoprotein hormone subunit genes in bilateral metazoa: identification of two novel human glycoprotein hormone subunit family genes, GPA2 and GPB5. Mol Endocrinol 16: 1538–1551.
[64]
Nakabayashi K, Matsumi H, Bhalla A, Bae J, Mosselman S, et al. (2002) Thyrostimulin, a heterodimer of two new human glycoprotein hormone subunits, activates the thyroid-stimulating hormone receptor. J Clin Invest 109: 1445–1452.
[65]
Park JI, Semyonov J, Chang CL, Hsu SY (2005) Conservation of the heterodimeric glycoprotein hormone subunit family proteins and the LGR signaling system from nematodes to humans. Endocrine 26: 267–276.
[66]
Sellami A, Agricola HJ, Veenstra JA (2011) Neuroendocrine cells in Drosophila melanogaster producing GPA2/GPB5, a hormone with homology to LH, FSH and TSH. Gen Comp Endocrinol 170: 582–588.
[67]
Okada SL, Ellsworth JL, Durnam DM, Haugen HS, Holloway JL, et al. (2006) A glycoprotein hormone expressed in corticotrophs exhibits unique binding properties on thyroid-stimulating hormone receptor. Mol Endocrinol 20: 414–425.
[68]
Kleinau G, Hoyer I, Kreuchwig A, Haas AK, Rutz C, et al. (2011) From Molecular Details of the Interplay between Transmembrane Helices of the Thyrotropin Receptor to General Aspects of Signal Transduction in Family A G-protein-coupled Receptors (GPCRs). J Biol Chem 286: 25859–25871.
[69]
Chen CR, Salazar LM, McLachlan SM, Rapoport B (2012) The thyrotropin receptor hinge region as a surrogate ligand: identification of Loci contributing to the coupling of thyrotropin binding and receptor activation. Endocrinology 153: 5058–5067.
[70]
Grossmann M, Weintraub BD, Szkudlinski MW (1997) Novel insights into the molecular mechanisms of human thyrotropin action: structural, physiological, and therapeutic implications for the glycoprotein hormone family. Endocr Rev 18: 476–501.
[71]
Szkudlinski MW, Grossmann M, Weintraub BD (1996) Structure-function studies of human TSH: new advances in design of glycoprotein hormone analogs. Trends Endocrinol Metab 7: 277–286.
[72]
Allen MD, Neumann S, Gershengorn MC (2011) Occupancy of both sites on the thyrotropin (TSH) receptor dimer is necessary for phosphoinositide signaling. FASEB J 25: 3687–3694.
[73]
Van Sande J, Massart C, Costagliola S, Allgeier A, Cetani F, et al. (1996) Specific activation of the thyrotropin receptor by trypsin. Mol Cell Endocrinol 119: 161–168.
[74]
Vu MT, Radu A, Ghinea N (2009) The cleavage of thyroid-stimulating hormone receptor is dependent on cell-cell contacts and regulates the hormonal stimulation of phospholipase c. J Cell Mol Med 13: 2253–2260.
[75]
Montanelli L, Van Durme JJ, Smits G, Bonomi M, Rodien P, et al. (2004) Modulation of ligand selectivity associated with activation of the transmembrane region of the human follitropin receptor. Mol Endocrinol 18: 2061–2073.
[76]
Bolonkin D, Tate RL, Luber JH, Kohn LD, Winand RJ (1975) Experimental exophthalmos. Binding of thyrotropin and an exophthalmogenic factor derived from thyrotropin to retro-orbital tissue plasma membranes. J Biol Chem 250: 6516–6521.
[77]
Chazenbalk GD, Kakinuma A, Jaume JC, McLachlan SM, Rapoport B (1996) Evidence for negative cooperativity among human thyrotropin receptors overexpressed in mammalian cells. Endocrinology 137: 4586–4591.
[78]
Tate RL, Schwartz HI, Holmes JM, Kohn LD (1975) Thyrotropin receptors in thyroid plasma membranes. Characteristics of thyrotropin binding and solubilization of thyrotropin receptor activity by tryptic digestion. J Biol Chem 250: 6509–6515.
[79]
Jeoung M, Lee C, Ji I, Ji TH (2007) Trans-activation, cis-activation and signal selection of gonadotropin receptors. MolCell Endocrinol 260–262: 137–143.
[80]
Alvarez E, Cahoreau C, Combarnous Y (2009) Comparative structure analyses of cystine knot-containing molecules with eight aminoacyl ring including glycoprotein hormones (GPH) alpha and beta subunits and GPH-related A2 (GPA2) and B5 (GPB5) molecules. Reprod Biol Endocrinol 7: 90.
[81]
Okajima Y, Nagasaki H, Suzuki C, Suga H, Ozaki N, et al. (2008) Biochemical roles of the oligosaccharide chains in thyrostimulin, a heterodimeric hormone of glycoprotein hormone subunits alpha 2 (GPA2) and beta 5 (GPB5). Regul Pept 148: 62–67.
